Tirzepatide pens contain a novel dual GIP and GLP-1 receptor agonist peptide currently under investigation for metabolic research applications. Our pharmaceutical-grade formulation meets strict quality standards for research use.
The white lyophilized powder is supplied in sterile vials with rubber stoppers and aluminum seals. Each tirzepatide pen formulation maintains stability when stored properly at 2-8°C. The molecular weight of 4813.5 Da corresponds to the C225H348N48O68 structure.
Our manufacturing facility produces tirzepatide pens under controlled conditions to ensure batch-to-batch consistency. The product undergoes rigorous HPLC analysis with purity exceeding 98% in all batches. Researchers can request Certificates of Analysis for specific lots.
Available in standard concentrations from 2mg to 30mg per vial, with custom formulations available for specialized research protocols. Bulk packaging options include 10 vials per box as standard, with larger quantity configurations upon request.
For research use only. Not for human consumption. Proper storage conditions are critical for maintaining peptide stability - store unopened tirzepatide pens at 2-8°C for short term use or -20°C for long term preservation.